N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N-(3-ethylphenyl)-N~2~-methylglycinamide
Chemical Structure Depiction of
N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N-(3-ethylphenyl)-N~2~-methylglycinamide
N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N-(3-ethylphenyl)-N~2~-methylglycinamide
Compound characteristics
Compound ID: | K906-3271 |
Compound Name: | N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N-(3-ethylphenyl)-N~2~-methylglycinamide |
Molecular Weight: | 430.48 |
Molecular Formula: | C20 H22 N4 O5 S |
Smiles: | CCc1cccc(c1)NC(CN(C)S(c1ccc2c(c1)C(NCC(N2)=O)=O)(=O)=O)=O |
Stereo: | ACHIRAL |
logP: | 2.2727 |
logD: | 1.7395 |
logSw: | -3.1278 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 3 |
Polar surface area: | 106.115 |
InChI Key: | PNABTFILNFDWQM-UHFFFAOYSA-N |